Waterstone Pharmaceutical (Wuhan) Co., LTD.
3 clinical trials · Sponsor
◉ Watch Waterstone Pharmaceutical (Wuhan) Co., LTD.
| Record | Firm | Date |
|---|---|---|
| A Two-Part, Phase 3 Study Evaluating the Efficacy and Safety of WS016 for the Treatment of Hyperkalemia (NCT07251309) | Waterstone Pharmaceutical (Wuhan) Co., LTD. | 2024-12-23 |
| A Study to Evaluate the Safety and Efficacy of WS016 in Patients With Hyperkalemia. (NCT06277128) | Waterstone Pharmaceutical (Wuhan) Co., LTD. | 2023-09-11 |
| The Safety and Tolerability of WS016 in Healthy Chinese Volunteers (NCT06281470) | Waterstone Pharmaceutical (Wuhan) Co., LTD. | 2023-02-13 |
Track Waterstone Pharmaceutical (Wuhan) Co., LTD. automatically
Every clearance here is in the API, with alerts when new ones post.